| 2025 | 2024 | 2023 | 2022 | 2021 | 2019 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | |||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| EBITDA | -127,9 k € | +21.5% | -162,8 k € | +14.7% | -191,0 k € | +2.6% | -196,0 k € | +17.8% | -238,6 k € | -12413.6% | 1,9 k € | +100.5% | -408,2 k € | +44.1% | -729,7 k € | +43.4% | -1,3 M € | +7.5% | -1,4 M € | +0.0% | -1,4 M € | +0.3% | -1,4 M € | -0.5% | -1,4 M € | -0.2% | -1,4 M € | +2.4% | -1,4 M € | -0.9% | -1,4 M € | |
| Operating profit | -146,2 k € | +16.6% | -175,2 k € | -35164.5% | 499,7 € | -76.2% | 2,1 k € | +561.7% | -454,8 € | -123.5% | 1,9 k € | +100.5% | -408,2 k € | +44.1% | -729,7 k € | +43.4% | -1,3 M € | +7.5% | -1,4 M € | +0.0% | -1,4 M € | +0.3% | -1,4 M € | +22.0% | -1,8 M € | +16.1% | -2,1 M € | +1.6% | -2,2 M € | -0.6% | -2,2 M € | |
| Profit/loss | -41,5 k € | -3840.8% | 1,1 k € | -99.8% | 662,3 k € | +11.9% | 592,1 k € | +601.3% | 84,4 k € | -92.3% | 1,1 M € | -85.2% | 7,4 M € | +35.6% | 5,5 M € | +248.0% | -3,7 M € | +52.6% | -7,8 M € | +39.6% | -12,9 M € | -118.7% | -5,9 M € | +6.8% | -6,3 M € | -15.8% | -5,5 M € | +30.4% | -7,8 M € | -85.5% | -4,2 M € | |
| Equity | 3,8 M € | -1.1% | 3,8 M € | +0.0% | 3,8 M € | +21.1% | 3,1 M € | +23.2% | 2,6 M € | -37.0% | 4,1 M € | -87.6% | 32,7 M € | +29.2% | 25,3 M € | +27.5% | 19,9 M € | -15.7% | 23,6 M € | -24.8% | 31,3 M € | -29.1% | 44,2 M € | -11.8% | 50,1 M € | -11.2% | 56,4 M € | -8.8% | 61,9 M € | -11.2% | 69,7 M € | |
| Total assets | 3,9 M € | -0.8% | 3,9 M € | +0.7% | 3,9 M € | +13.7% | 3,4 M € | +13.0% | 3,0 M € | -42.8% | 5,3 M € | -93.8% | 84,9 M € | +12.2% | 75,7 M € | +10.6% | 68,4 M € | -3.3% | 70,7 M € | -7.9% | 76,8 M € | -12.9% | 88,1 M € | -4.7% | 92,5 M € | -5.2% | 97,5 M € | -4.2% | 101,7 M € | -5.7% | 107,9 M € | |
| Cash | 58,4 k € | -67.3% | 178,3 k € | -3.3% | 184,4 k € | +470.4% | 32,3 k € | -98.2% | 1,8 M € | +42.1% | 1,3 M € | -97.9% | 60,8 M € | +23.2% | 49,4 M € | +41.7% | 34,8 M € | +152.8% | 13,8 M € | +16.9% | 11,8 M € | -45.1% | 21,5 M € | +39.9% | 15,4 M € | +0.0% | 15,3 M € | +204.0% | 5,0 M € | +135.8% | 2,1 M € | |
| Debts | 2,4 k € | -79.8% | 12,0 k € | — | — | — | 12,3 k € | -100.0% | 51,6 M € | +3.6% | 49,8 M € | +3.8% | 48,0 M € | +2.9% | 46,6 M € | +3.8% | 44,9 M € | +3.6% | 43,4 M € | +3.8% | 41,8 M € | +3.3% | 40,4 M € | +3.5% | 39,1 M € | +3.8% | 37,6 M € | |||||
Public limited company · Bruxelles · incorporated on 09/06/2005
Company — Voluntary dissolution - liquidation.
Public limited company loss-making in the latest fiscal year. Cash position declining (-67.3%).
Solid counterparty for a standard engagement.
ARKimedes-Fonds is a Public limited company incorporated in 2005. Its registered office is in Bruxelles.
Key indicators
7-day free trial, no credit card required.
7-day free trial, no credit card required.
7-day free trial, no credit card required.
Source: Belgian Official Gazette